Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

Systems have been put in place in the Mayo Clinic Stem Cell Transplantation program to reduce day-100 all-cause mortality. Currently our mortality has been reduced to 0.3%. Patients can undergo transplant as an outpatient, with a median hospital duration of 0 days and only 25% of patients requiring a hospital stay of 5 days or greater. Outpatient transplantation is safe and reduces patient-incurred costs.

Original languageEnglish (US)
Pages (from-to)56-58
Number of pages3
JournalMayo Clinic Proceedings
Volume93
Issue number1
DOIs
StatePublished - Jan 1 2018

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma'. Together they form a unique fingerprint.

  • Cite this